Publications by authors named "Phoebe Sharp"

Claim this Profile
Q
Quantitation of Synthetic Cannabinoid Receptor Agonists in Postmortem Blood Using a Single Point Calibration.
Phoebe Sharp, Simon Hudson, Stephen R Morley

Acad Forensic Pathol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasonic Bone Assessment Using the Backscatter Amplitude Decay Constant.
Brent K Hoffmeister, Aubrey J Gray, Phoebe C Sharp, Luke C Fairbanks, Jinsong Huang

Ultrasound Med Biol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis.
Maria Weiner, Su Mein Goh, Aladdin J Mohammad, Zdenka Hrušková, Anisha Tanna, Phoebe Sharp

J Rheumatol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The changing pattern of synthetic cannabinoid use within England, April 2014 to March 2018.
Phoebe Sharp, Simon Hudson, Laura Hikin, Paul R Smith, Stephen R Morley

Med Sci Law· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The host cellular immune response to cytomegalovirus targets the endothelium and is associated with increased arterial stiffness in ANCA-associated vasculitis.
Dimitrios Chanouzas, Michael Sagmeister, Lovesh Dyall, Phoebe Sharp, Lucy Powley

Arthritis Res Ther· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FcγRIIb on myeloid cells and intrinsic renal cells rather than B cells protects from nephrotoxic nephritis.
Phoebe E H Sharp, Javier Martin-Ramirez, Sara M Mangsbo, Peter Boross, Charles D Pusey

J Immunol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased incidence of anti-GBM disease in Fcgamma receptor 2b deficient mice, but not mice with conditional deletion of Fcgr2b on either B cells or myeloid cells alone.
Phoebe E H Sharp, Javier Martin-Ramirez, Peter Boross, Sara M Mangsbo, John Reynolds

Mol Immunol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mice with defective Fas ligand are protected from crescentic glomerulonephritis.
Ruth M Tarzi, Phoebe E H Sharp, John P McDaid, Liliane Fossati-Jimack, Paul E Herbert

Kidney Int· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis